Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hickling

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Clinical and Experimental Immunology|February 13, 2018
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximabB Gorovits, D J Baltrukonis, I Bhattacharya, et al.
The Journal of General Virology|August 16, 2005
Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsetsEriko Yamada, Maria Montoya, Christian G Schuettler, et al.
Cells|April 9, 2014
CD8+ T Lymphocyte Epitopes From The Herpes Simplex Virus Type 2 ICP27, VP22 and VP13/14 Proteins To Facilitate Vaccine Design And CharacterizationRebecca J Platt, Tansi Khodai, Tim J Townend, et al.
Cell Reports. Medicine|October 23, 2025
Current regulatory requirements for assessment of immunogenicity for gene therapy medicinal productsChristopher J Mann, Jon Giblin, Manuela Braun, et al.
Communications Biology|July 31, 2025
HLAIIPred: cross-attention mechanism for modeling the interaction of HLA class II molecules with peptidesMojtaba Haghighatlari, Nicholas Marze, Robert Seward, et al.
Clinical and Experimental Immunology|December 21, 2006
Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complexK S Brown, M J Keogh, N Tagiuri, et al.
Rheumatology (Oxford, England)|January 2, 2003
Changes in rheumatology out-patient workload over 12 years in the South West of EnglandJ R Kirwan, H Averns, P Creamer, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33Alexander W Tarr, Ania M Owsianka, Judith M Timms, et al.
Protein & Cell|January 5, 2011
Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entryKristelle S Brown, Michael J Keogh, Ania M Owsianka, et al.
Frontiers in Immunology|September 12, 2024
Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicityMichel Siegel, Anna-Lena Bolender, Axel Ducret, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Immunology|February 13, 2018
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximabB Gorovits, D J Baltrukonis, I Bhattacharya, et al.
The Journal of General Virology|August 16, 2005
Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsetsEriko Yamada, Maria Montoya, Christian G Schuettler, et al.
Cells|April 9, 2014
CD8+ T Lymphocyte Epitopes From The Herpes Simplex Virus Type 2 ICP27, VP22 and VP13/14 Proteins To Facilitate Vaccine Design And CharacterizationRebecca J Platt, Tansi Khodai, Tim J Townend, et al.
Cell Reports. Medicine|October 23, 2025
Current regulatory requirements for assessment of immunogenicity for gene therapy medicinal productsChristopher J Mann, Jon Giblin, Manuela Braun, et al.
Communications Biology|July 31, 2025
HLAIIPred: cross-attention mechanism for modeling the interaction of HLA class II molecules with peptidesMojtaba Haghighatlari, Nicholas Marze, Robert Seward, et al.
Clinical and Experimental Immunology|December 21, 2006
Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complexK S Brown, M J Keogh, N Tagiuri, et al.
Rheumatology (Oxford, England)|January 2, 2003
Changes in rheumatology out-patient workload over 12 years in the South West of EnglandJ R Kirwan, H Averns, P Creamer, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33Alexander W Tarr, Ania M Owsianka, Judith M Timms, et al.
Protein & Cell|January 5, 2011
Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entryKristelle S Brown, Michael J Keogh, Ania M Owsianka, et al.
Frontiers in Immunology|September 12, 2024
Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicityMichel Siegel, Anna-Lena Bolender, Axel Ducret, et al.
Pageof 10